Subthalamic nucleus stimulation in Parkinson’s disease
✍ Scribed by F. Godinho; S. Thobois; M. Magnin; M. Guenot; G. Polo; I. Benatru; J. Xie; A. Salvetti; L. Garcia-Larrea; E. Broussolle; P. Mertens
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 241 KB
- Volume
- 253
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Deep brain stimulation of the subthalamic nuclei (STN) is a good therapeutic option to reduce dyskinesias and improve appendicular motor signs in well‐selected patients with advanced Parkinson's disease (PD). Concerns about long‐term adverse effects play an increasingly role in the deci
## Abstract A slight decline in cognitive functions and especially in executive functioning after deep brain stimulation (DBS) of the nucleus subthalamicus (STN) in patients with Parkinson's disease (PD) has been described. This study evaluated baseline parameters that contribute to a deterioration
## Abstract The efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease (PD) is well‐established but little is known about the lifetime of implanted pulse generators (IPG). To investigate the lifetime of the bilaterally implanted Itrel II® (Medtronic, Minneapolis) pulse g